Advances in the Diagnosis and Treatment of Pulmonary Vascular Diseases
A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Cardiovascular Clinical Research".
Deadline for manuscript submissions: closed (15 August 2023) | Viewed by 4781
Special Issue Editor
Interests: pulmonary hypertension; chronic thromboembolic pulmonary disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is my privilege to invite you to this Special Issue of the Journal of Cardiovascular Development and Disease titled “Advances in Diagnosis and Treatment of Pulmonary Vascular Diseases”. We dedicate this issue mainly but not solely to pulmonary hypertension (PAH) and other diseases of pulmonary circulation.
The definition of pulmonary hypertension has been revised by recent guidelines of the European Society of Cardiology, but how this change can affect epidemiology of this disease, the approach to its management, and patients’ outcome are not well known. Therefore, in the present issue, we are going to prioritize studies which enroll patients with pulmonary hypertension diagnosed based on the novel definition.
The clinical characteristics of the PAH population have been changing in recent decades. Currently, a significant number of patients are more than 65 years old at the time of diagnosis and have several different diseases when PAH is diagnosed. Thus, of special interest is differential diagnosis between PAH and other forms of pulmonary hypertension, including those due to left heart diseases and due to diseases of the respiratory system. We are also interested in papers presenting how different comorbidities can affect patients’ outcome.
PAH is very rare in the pediatric population, and there is a paucity of data from clinical studies on the optimal therapy of PAH in this population. Therefore, epidemiological data on PAH in children, cohort studies analyzing clinical outcomes, as well as clinical trials in this field are within scope in the present issue of the Journal of Clinical Medicine.
Despite increasing knowledge on PAH mechanisms, the etiology of this disease is still not well understood. Accordingly, studies presenting new data from preclinical studies on the pathophysiology of human PAH, especially with use of the emerging -omics technologies, will be considered in the present issue.
Recently, we have also observed a revolution in the treatment modalities of other diseases of pulmonary circulation, including pulmonary embolism and congenital malformations. This Special Issue will thus accept clinically important studies in this field.
Dr. Grzegorz Kopec
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary hypertension
- pulmonary embolism
- venous thromboembolic disease
- pulmonary vascular disease
- congenital heart disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
